Lung cancer conference to focus on new diagnostic techniques, potential treatments
Lung cancer is the most commonly diagnosed cancer in the United States and often the most fatal unless caught early, but scientists are working on ways to improve their understanding of the disease.
Several hundred of scientists will gather in San Diego at the San Diego Marriott Marquis & Marina during Jan. 8-11, 2012, for the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy and Personalized Medicine.
The conference is jointly sponsored by the American Association for Cancer Research and the International Association for the Study of Lung Cancer.
Media are welcome to attend the conference and can register by contacting Jeremy Moore at Jeremy.Moore@aacr.org.
The conference will host a media briefing, entitled "Lung Cancer Diagnosis: Pitfalls, Challenges and the Path Ahead," on Tuesday, Jan. 10 at 1:00 p.m. PT (4:00 p.m. ET). The briefing will be held in the Atlanta/Chicago room of the San Diego Marriott Marquis & Marina.
The following leaders in lung cancer are scheduled to speak at the press conference:
- Roy Herbst, M.D., Ph.D., chief of medical oncology and associate director for translational research at the Yale Cancer Center;
- David P. Carbone, M.D., Ph.D., Harold L. Moses chair in cancer research, director of the Specialized Program of Research Excellence in Lung Cancer and co-leader of the Thoracic/Head and Neck Research Program at the Vanderbilt-Ingram Cancer Center; and
- Paul A. Bunn, M.D., professor and James Dudley chair in cancer research at the University of Colorado School of Medicine.
U.S./Canada (Toll Free): 888-647-7462
International (Toll): 201-604-0169
Conference leaders have also designated the following research as newsworthy:
Provided by American Association for Cancer Research